EP3 Learning from the World’s First Biosimilar Trastuzumab: Jyoti

April 4, 2025

Biosimilar Trastuzumab

In this episode, we are honored to host Jyoti Iyer, Vice President for Product Development at Biofusion Therapeutics, in a thought-provoking discussion facilitated by Dr. Narendra Chirmule, CEO at SymphonyTech Biologics.

A well-known name in both scientific and industry circles, Jyoti Iyer played a pivotal role in developing the world’s first biosimilar to Trastuzumab, transforming the landscape of biologics. But her impact goes beyond science—she is also deeply committed to social change, dedicating her time to an orphanage in Bangalore.

🔑 Key Takeaways:
✔️ Success is fleeting—enjoy it, share it, and move forward.
✔️ Taking a step back can help redefine priorities.
✔️ “My life is my message”—a philosophy that guides her journey.

💡 Key Questions Answered:
1️⃣ How is it to join the industry immediately after a PhD?
2️⃣ What should you choose—Postdoc or Industry?
3️⃣ Should you go abroad or stay back in India?
4️⃣ How does mentorship shape career decisions?
5️⃣ The role of humbleness, spirituality, and leadership in success.

YouTube video link: https://youtu.be/OAHmGTWbazk

📌 Connect with Jyoti Iyer on LinkedIn: https://www.linkedin.com/in/jyotiiyer/

🔖 #Mentorship #Biotech #RnD #Industry #CareerGrowth #leadershipdevelopment

About Mentor Konnect

🎓 Inspiring Minds. Connecting Journeys.

Mentor Konnect is a storytelling and mentorship series by BioPatrika, designed to bridge the gap between aspiring scientists, professionals, and accomplished leaders across diverse fields—spanning biotech, physics, academia, industry, and beyond.

Each episode features an in-depth conversation with a trailblazer who shares personal career journeys, pivotal mentorship moments, challenges faced, and the mindset needed to navigate growth and transitions.

Whether you’re a student, researcher, postdoc, or industry professional, Mentor Konnect offers a unique blend of wisdom, warmth, and real-world guidance to help you carve your own path with confidence.